Studies have reported a significant drop in the IL-1 receptor antagonists to IL-1 ratio in IBD patients, suggestive of the significance of the IL-1 pathway in the exacerbation of IBD [66]. The gene discussed is IL1B; the disease is inflammatory bowel disease.